For tirzepatide versus semaglutide, contrary to the primary endpoint in the head-to-head comparison, there was some supporting evidence for tirzepatide to have a modest benefit, although the 95% CI overlapped the null (HR 0.91, 95% CI 0.81 to 1.01) (Fig
The study was coauthored by Rafeya Raquib, research fellow in the Department of Global Health at SPH
Using national poison control data, UT San Antonio researchers uncover a dramatic rise in semaglutide-related calls following FDA approval for weight management
Certain foods are more likely to cause side effects or slow progress
If it does not, you have a visual baseline for comparison and a photo to share with the pharmacy when you call
RA is caused by the immune system attacking the joints, so any medication that could alter immune responses might theoretically help in managing RA symptoms